Yaupon Therapeutics clinical trials
Acquired by Johnson & Johnson, Jun 16, 2017 · source ↗
The registry lists 3 studies whose lead sponsor is Yaupon Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 20, 2013.
Before and after it joined Johnson & Johnson
- First submitted before Yaupon Therapeutics became part of Johnson & Johnson
- 3
- First submitted after Yaupon Therapeutics became part of Johnson & Johnson
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Yaupon Therapeutics3 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Johnson & Johnson studies →
- Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult PatientsCompletedNCT00664703Phase 2
Sponsor listed in the registry: Yaupon Therapeutics · First submitted before Yaupon Therapeutics became part of Johnson & Johnson
- Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis FungoidesCompletedNCT00168064Phase 2
Sponsor listed in the registry: Yaupon Therapeutics · First submitted before Yaupon Therapeutics became part of Johnson & Johnson
- An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis FungoidesCompletedNCT00535470Phase 2
Sponsor listed in the registry: Yaupon Therapeutics · First submitted before Yaupon Therapeutics became part of Johnson & Johnson